科研製薬株式会社 · KAKEN PHARMACEUTICAL CO., LTD.
Last · —$3810.00+25.00 (+0.66%)live · yahoo · 0s ago
Market cap——
P/E · TTM67.8fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | ¥76.9B |
|---|---|
| Operating income | ¥-899.0M |
| Net income | ¥2.1B |
| Free cash flow | ¥-14.8B |
| Operating margin | -1.2% |
| Net margin | 2.8% |
| Return on equity | 1.6% |
| Period | 2026 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-06-25
- Operating Cf Burn
Red flags
- Operating Cf Burn — Negative operating cash flow
Upcoming earnings
7:30 AM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
Documents
FormReporting forFiledFlags